tiprankstipranks
Trending News
More News >
Seres Therapeutics Inc. (MCRB)
:MCRB
US Market

Seres Therapeutics (MCRB) Income Statement

Compare
1,079 Followers

Seres Therapeutics Income Statement

Last quarter (Q3 2025), Seres Therapeutics's total revenue was $351.00K, an increase of Infinity% from the same quarter last year. In Q3, Seres Therapeutics's net income was $8.20M. See Seres Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 144.93M$ 33.22M
Gross Profit
$ -3.53M$ 0.00$ 0.00$ 144.93M$ -57.35M
Operating Expenses
$ 117.78M$ 195.10M$ 179.91M$ 209.42M$ 30.77M
Depreciation and Amortization
$ 5.47M$ 6.24M$ 6.63M$ 5.95M$ 8.89M
EBITDA
$ -120.30M$ -181.42M$ -170.93M$ -56.72M$ -77.31M
Operating Income
$ -121.31M$ -195.10M$ -179.91M$ -64.49M$ -88.13M
Other Income/Expenses
$ -4.46M$ 4.97M$ -3.67M$ -1.08M$ -997.00K
Pretax Income
$ -125.77M$ -190.13M$ -183.58M$ -65.58M$ -89.13M
Net Income
$ 136.00K$ -113.72M$ -250.16M$ -65.58M$ -89.13M
Per Share Metrics
Basic EPS
$ -18.86$ -17.77$ -46.29$ -14.30$ -22.34
Diluted EPS
$ -18.86$ -17.77$ -46.29$ -14.30$ -22.34
Weighted Average Shares Outstanding
7.77M 6.40M 5.40M 4.59M 3.99M
Weighted Average Shares Outstanding (Diluted)
7.77M 6.40M 5.40M 4.59M 3.99M
Currency in USD

Seres Therapeutics Earnings and Revenue History